ApoB-100 secretion by HepG2 cells is regulated by the rate of triglyceride biosynthesis but not by intracellular lipid pools

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 10, 1996, Pages 1229-1235

  Benoist, Fabienne ^a   Grand Perret, Thierry ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

5 tetradecyloxy 2 furancarboxylic acid; cholesteryl ester; hepatocyte; lipoprotein assembly

Indexed keywords

1 (5 TETRADECYLOXY 2 FURANYL)ETHANONE; APOLIPOPROTEIN B100; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; SIMVASTATIN; TRIACYLGLYCEROL;

ARTICLE; CELL LEVEL; CELL MEMBRANE TRANSPORT; DRUG EFFECT; HUMAN; HUMAN CELL; LIPID TRANSPORT; LIPOPROTEIN SYNTHESIS; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0029795221     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.10.1229     Document Type: Article

References (44)

1. Janus ED, Nicoll AM, Turner PR, Magill P, Lewis B. Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein B turnover in genetically defined subjects. Eur J Clin Invest. 1980;10:161-172.
2. Vega GL, Denke MA, Grundy SM. Metabolic basis of primary hypercholesterolemia. Circulation. 1991;84:118-128.
3. Leighton JK, Joyner J, Zamarripa J, Deines M. Fasting decreases apolipoprotein B mRNA editing and secretion of small molecular weight apoB by rat hepatocytes: evidence that the total amount of apoB secreted is regulated post-transcriptionally. J Lipid Res. 1990;31:1663-1668.
4. Srivastava RAK, Jiao S, Tang, J. Pfeger BA, Kitchens RT, Schonfeld G. In vivo regulation of low-density lipoprotein receptor and apolipoprotein B gene expressions by dietary fat and cholesterol in inbred strains of mice. Biochim Biophys Acta. 1991;1086:29-43.
5. Pape ME, Castle CK, Murray RW, Funk GM, Hunt CE, Marotti KR. Apo B metabolism in the cynomolgus monkey: evidence for post-transcriptional regulation. Biochim Biophys Acta. 1991;1086:326-334.
6. Kroon PA, DeMartino JA, Thompson GM, Chao YS. Molecular cloning of partial cDNAs for rabbit liver apolipoprotein B and the regulation of its mRNA levels by dietary cholesterol. Proc Natl Acad Sci U S A. 1986;89:5071-5075.
7. Sorci-Thomas M, Wilson MD, Johnson FL, Williams DL, Rudel LL. Studies on the expression of genes encoding apolipoproteins B100 and B48 and the low density lipoprotein receptor in nonhuman primates: comparison of dietary fat and cholesterol. J Biol Chem. 1989;264:9039-9045.
8. Pullinger CR, North JD, Teng BB, Rifici VA, Ronhild de Brito AE, Scott J. The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res. 1989;30:1065-1077.
9. Moberly JB, Cole TG, Alpers DH, Schonfeld G. Oleic acid stimulation of apolipoprotein B secretion from HepG2 and Caco-2 cells occurs post-transcriptionally. Biochim Biophys Acta. 1990;1042:70-80.
10. Dixon JL, Furukawa S, Ginsberg HN. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from HepG2 cells by inhibiting early intracellular degradation of apolipoprotein B. J Biol Chem. 1991;266:5080-5086.
11. Dashti N. The effect of low density lipoproteins, cholesterol, and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells. J Biol Chem. 1992;267:7160-7169.
12. Dashti N, Williams DL, Alaupovic P. Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells. J Lipid Res. 1989;30:1365-1373.
13. Kaptein A, Roodenberg L, Princen MG. Butyrate stimulates the secretion of apolipoprotein (apo) A-I and apoB100 by the human hepatoma cell line HepG 2: induction of apo A-I mRNA with no change of apo B100 mRNA. Biochem J. 1991;278:557-564.
14. Du EZ, Kurth J, Wang SL, Humiston P, Davis RA. Proteolysis-coupled secretion of the N terminus apolipoprotein B: characterisation of a transient, translocation arrested intermediate. J Biol Chem. 1994;269:24169-24176.
15. Benoist F, Grand-Perret T. A very sensitive method to analyze in vitro secretion of lipoproteins: distribution of apolipoproteins is modulated by oleic acid in HepG2 cells. J Lipid Res. 1995;36:2243-2250.
16. Rash JM, Rothblat GH, Sparks CE. Lipoprotein apolipoprotein synthesis by human hepatoma cells in culture. Biochim Biophys Acta. 1981;666:294-298.
17. Erickson SK, Fielding PE. Parameters of cholesterol metabolism in the human hepatoma cell line, HepG2. J Lipid Res. 1986;27:875-883.
18. Dashti N, Wolfbauer G. Secretion of lipids, apolipoproteins, and lipoproteins by human hepatoma cell line, HepG2: effects of oleic acid and insulin. J Lipid Res. 1987;28:423-436.
19. Arrol S, Mackness MI, Laing I, Durrington PN. Lipoprotein secretion by the human hepatoma cell line HepG2: differential rates of accumulation of apolipoprotein B and lipoprotein lipids in tissue culture media in response to albumin, glucose and oleate. Biochim Biophys Acta. 1991;1086:72-80.
20. Kurokawa M, Hirano T, Furukawa S, Nagano S, Adachi M. Similar to oleic acid, eicosapentaenoic acid stimulates apolipoprotein B secretion by inhibiting its intracellular degradation in HepG2 cells. Atherosclerosis. 1995;112:59-68.
21. Boren J, Wettesten M, Sjoberg A, Thorlin T, Bondjers G, Wiklund O, Olofsson SO. The assembly and secretion of apoB 100 containing lipoproteins in HepG2 cells: evidence for different sites for protein synthesis and lipoprotein assembly. J Biol Chem. 1990;265:10556-10564.
22. Wu X, Sakata N, Dixon J, Ginsberg HN. Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester. J Lipid Res. 1994;35:1200-1210.
23. Arbeeny CM, Meyers DS, Bergquist KE, Gregg RE. Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster. J Lipid Res. 1992;33:843-851.
24. Kempen HM, Imbach AP, Gille T, Neumann WJ, Hennes U, Nakada N. Secretion of apolipoproteins A-I and B by HepG2 cells: regulation by substrates and metabolic inhibitors. J Lipid Res. 1995;36:1796-1806.
25. Arad Y, Ramakrishnan R, Ginsberg HN. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apo B-containing lipoproteins: implications for the pathophysiology of apoB production. J Lipid Res. 1990;31:567-582.
26. Ginsberg HN, Le NA, Short MP, Ramakrishnan R, Desnick RJ. Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin: implications for regulation of apolipoprotein B synthesis. J Clin Invest. 1987;80:1692-1697.
27. Fuki IV, Preobrazhensky SN, Misharin AY, Bushmakina NG, Menschikov GB, Repin VS, Karpov RS. Effect of cell cholesterol content on apolipoprotein B secretion and LDL receptor activity in the human hepatoma cell line, HepG2. Biochim Biophys Acta. 1989;1001:235-238.
28. Sato R, Imanaka T, Takano T. The effect of HMG-CoA reductase inhibitor (CS-514) on the synthesis and secretion of apolipoproteins B and A-1 in the human hepatoblastoma HepG2. Biochim Biophys Acta. 1990;1042:36-41.
29. Cianflone KM, Yasruel Z, Rodriguez MA, Vas D, Sniderman AD. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. J Lipid Res. 1990;31:2045-2055.
30. Furukawa S, Hirano T. Rapid stimulation of apolipoprotein B secretion by oleate is not associated with cholesteryl ester biosynthesis in HepG2 cells. Biochim Biophys Acta. 1993;1170:32-37.
31. Yao ZM, Vance DE. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem. 1988;263:2998-3004.
32. Vance JE. Secretion of VLDL, but not HDL, by rat hepatocytes is inhibited by the ethanolamine analogue N-monomethylemanolamine. J Lipid Res. 1991;32:1971-1982.
33. Verkade HJ, Fast DG, Rusinol AE, Scraba DG, Vance DE. Impaired biosynthesis of phosphatidylcholine causes a decrease in the number of very low density lipoprotein particles in the Golgi but not in the endoplasmic reticulum of rat liver. J Biol Chem. 1993;268:24990-24996.
34. Fast DG, Lingrell S, Yao Z, Vance DE. Impaired phosphatidylcholine biosynthesis causes abnormal degradation of apoB in a post-endoplasmic reticulum compartment. Circulation. 1993;88(suppl I):I-132. Abstract.
35. Burger K. Description of the new multiple development technique (now called 'AMD'=Automated Multiple Development) using a stepwise elution gradient which starts with the most polar and ends with the nonpolar solvent: comparison with HPLC. Fresinius Z Anal Chem. 1984;318:228-233.
36. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
37. Kosykh VA, Surguchov AP, Podres EA, Novikov DK, Sudarickov AB, Berestetskaya YV, Repin VS, Smirnov VN. VLDL apoprotein secretion and apoB mRNA in primary culture of cholesterol loaded rabbit hepatocytes. FEBS Lett. 1988;232:103-106.
38. Holvoet P, Perez G, Bernar H, Brouwers E, Vanloo B, Rosseneu M, Collen D. Stimulation with a monoclonal antibody (mAb4E4) of scavenger receptor-mediated uptake of chemically modified low density lipoproteins by THP-1-derived macrophages enhances foam cell generation. J Clin Invest. 1994;93:89-98.
39. Gibbons GF, Khurana R, Odwell A, Seelaender MCL. Lipid balance in HepG2 cells: active synthesis and impaired mobilization. J Lipid Res. 1994;35:1801-1808.
40. Gordon DA, Jamil H, Sharp D, Mullaney D, Yao Z, Gregg RE, Wetterau J. Secretion of apolipoprotein B-containing lipoproteins from HeLa cells is dependent on expression of the microsomal triglyceride transfer protein and is regulated by lipid availability. Proc Natl Acad Sci U S A. 1994;91:7628-7632.
41. Wetterau JR, Aggerbeck LP, Bouma ME, Eisenberg C, Munck A, Hermier M, Schmitz J, Rader DJ, Gregg RE. Absence of microsomal transfer protein in individuals with abetalipoproteinemia. Science. 1990;258:999-1001.
42. Wetterau JR, Zilversmit DB. Purification and characterization of microsomal triglyceride and cholesteryl ester transfer protein from bovine liver microsomes. Chem Phys Lipids. 1985;38:205-222.
43. Gibbons GF. A comparison of in-vitro models to study hepatic lipid and lipoprotein metabolism. Curr Opin Lipidol. 1994;5:191-199.
44. Benoist F, Nicodeme E, Grand-Perret T. Microsomal triglyceride transfer protein prevents presecretory degradation of apolipoprotein B-100: a dithiothrictol sensitive protease is involved. Eur J Biochem. In press.